Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bijl

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Clinical Immunology (Orlando, Fla.)|September 17, 2011
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosusSebastian Dolff, Marc Bijl, Minke G Huitema, et al.
Rheumatology (Oxford, England)|September 17, 2016
High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cellsFleur Schaper, Karina de Leeuw, Gerda Horst, et al.
Autoimmunity|October 9, 2009
AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosisHans L A Nienhuis, Johanna Westra, Andries J Smit, et al.
Atherosclerosis|April 25, 2009
Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosusKarina de Leeuw, Andries J Smit, Eric de Groot, et al.
Molecular Medicine (Cambridge, Mass.)|February 3, 2016
Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr MiceFleur Schaper, Mirjan M van Timmeren, Arjen Petersen, et al.
Rheumatology (Oxford, England)|December 7, 2010
Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular diseaseJohanna Westra, Lodewijk de Groot, Shannon L Plaxton, et al.
Blood|March 18, 2004
The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosusJan-Leendert P Brouwer, Marc Bijl, Nic J G M Veeger, et al.
Arthritis Research & Therapy|September 7, 2013
Is serum HMGB1 a biomarker in ANCA-associated vasculitis?Alexandre de Souza, Johanna Westra, Johan Bijzet, et al.
Arthritis Research & Therapy|December 16, 2011
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled diseaseLodewijk de Groot, Helmy Hinkema, Johanna Westra, et al.
Arthritis and Rheumatism|April 16, 2002
Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosisMaarten M Boomsma, Marc Bijl, Coen A Stegeman, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Clinical Immunology (Orlando, Fla.)|September 17, 2011
Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosusSebastian Dolff, Marc Bijl, Minke G Huitema, et al.
Rheumatology (Oxford, England)|September 17, 2016
High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cellsFleur Schaper, Karina de Leeuw, Gerda Horst, et al.
Autoimmunity|October 9, 2009
AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosisHans L A Nienhuis, Johanna Westra, Andries J Smit, et al.
Atherosclerosis|April 25, 2009
Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosusKarina de Leeuw, Andries J Smit, Eric de Groot, et al.
Molecular Medicine (Cambridge, Mass.)|February 3, 2016
Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr MiceFleur Schaper, Mirjan M van Timmeren, Arjen Petersen, et al.
Rheumatology (Oxford, England)|December 7, 2010
Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular diseaseJohanna Westra, Lodewijk de Groot, Shannon L Plaxton, et al.
Blood|March 18, 2004
The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosusJan-Leendert P Brouwer, Marc Bijl, Nic J G M Veeger, et al.
Arthritis Research & Therapy|September 7, 2013
Is serum HMGB1 a biomarker in ANCA-associated vasculitis?Alexandre de Souza, Johanna Westra, Johan Bijzet, et al.
Arthritis Research & Therapy|December 16, 2011
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled diseaseLodewijk de Groot, Helmy Hinkema, Johanna Westra, et al.
Arthritis and Rheumatism|April 16, 2002
Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosisMaarten M Boomsma, Marc Bijl, Coen A Stegeman, et al.
Pageof 10